Kestle John R W, Drake James M, Cochrane D Douglas, Milner Ruth, Walker Marion L, Abbott Rick, Boop Frederick A
Division of Pediatric Neurosurgery, University of Utah, Primary Children's Medical Center, Salt Lake City, Utah 84113, USA.
J Neurosurg. 2003 Feb;98(2):284-90. doi: 10.3171/jns.2003.98.2.0284.
Endoscopically assisted ventricular catheter placement has been reported to reduce shunt failure in uncontrolled series. The authors investigated the efficacy of this procedure in a prospective multicenter randomized trial.
Children younger than 18 years old who were scheduled for their first ventriculoperitoneal (VP) shunt placement were randomized to undergo endoscopic or nonendoscopic insertion of a ventricular catheter. Eligibility and primary outcome (shunt failure) were decided in a blinded fashion. An intention-to-treat analysis was performed. The sample size offered 80% power to detect a 10 to 15% absolute reduction in the 1-year shunt failure rate. The authors studied 393 patients from 16 pediatric neurosurgery centers between May 1996 and November 1999. Median patient age at shunt insertion was 89 days. The baseline characteristics of patients within each group were similar: 54% of patients treated with endoscopy were male and 55% of patients treated without endoscopy were male; 30% of patients treated with and 26% of those without endoscopy had myelomeningocele; a differential pressure valve was used in 51% of patients with and 49% of those treated without endoscopy; a Delta valve was inserted in 38% of patients in each group; and a Sigma valve was placed in 9% of patients treated with and 12% of those treated without endoscopy. Median surgical time lasted 40 minutes in the group treated with and 35 minutes in the group treated without endoscopy. Ventricular catheters, which during surgery were thought to be situated away from the choroid plexus, were demonstrated to be in it on postoperative imaging in 67% of patients who had undergone endoscopic insertion and 61% of those who had undergone nonendoscopic shunt placements. The incidence of shunt failure at 1 year was 42% in the endoscopic insertion group and 34% in the nonendoscopic group. The time to first shunt failure was not different between the two groups (log rank = 2.92, p = 0.09).
Endoscopic insertion of the initial VP shunt in children suffering from hydrocephalus did not reduce the incidence of shunt failure.
据报道,在内镜辅助下放置脑室导管可减少非对照系列中的分流失败情况。作者在一项前瞻性多中心随机试验中研究了该手术的疗效。
计划首次进行脑室腹腔(VP)分流术的18岁以下儿童被随机分为接受内镜或非内镜下脑室导管插入术。以盲法确定入选标准和主要结局(分流失败)。进行意向性分析。样本量有80%的把握度检测出1年分流失败率绝对降低10%至15%。作者在1996年5月至1999年11月期间研究了来自16个儿科神经外科中心的393例患者。分流术时患者的中位年龄为89天。每组患者的基线特征相似:接受内镜治疗的患者中54%为男性,未接受内镜治疗的患者中55%为男性;接受内镜治疗的患者中有30%、未接受内镜治疗的患者中有26%患有脊髓脊膜膨出;接受内镜治疗的患者中有51%、未接受内镜治疗的患者中有49%使用了压差阀;每组中有38%的患者插入了Delta阀;接受内镜治疗的患者中有9%、未接受内镜治疗的患者中有12%放置了Sigma阀。接受内镜治疗组的中位手术时间为40分钟,未接受内镜治疗组为35分钟。手术中认为位于脉络丛之外的脑室导管,在术后影像学检查中,接受内镜插入术的患者中有67%、接受非内镜分流术的患者中有61%显示位于脉络丛内。内镜插入组1年时的分流失败发生率为42%,非内镜组为34%。两组首次分流失败的时间无差异(对数秩检验=2.92,p=0.09)。
在脑积水患儿中,首次VP分流术采用内镜插入并未降低分流失败的发生率。